Citation Impact
Citing Papers
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Role of endothelin-1 in lung disease
2001
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.
2000
A meta-analysis of trials of pulmonary hypertension: A clinical condition looking for drugs and research methodology
2007
Chimerism of the Transplanted Heart
2002 Standout
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Primary Pulmonary Hypertension
2000
Endothelin Peptides: Biological Activities, Cellular Signalling and Clinical Significance
1992
Clinical Efficacy of Sitaxsentan, an Endothelin-A Receptor Antagonist, in Patients With Pulmonary Arterial Hypertension
2002
Treatment of Pulmonary Arterial Hypertension
2004 Standout
New insights into nNOS regulation of vascular homeostasis
2005 StandoutNobel
Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide.
1995
Primary Pulmonary Hypertension
1997 Standout
Pulmonary Arterial Hypertension
2006
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
The Prognostic Value of Big Endothelin-1 in More Than 2,300 Patients With Heart Failure Enrolled in the Valsartan Heart Failure Trial (Val-HeFT)
2006
Endothelin production in sepsis and the adult respiratory distress syndrome
1996
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
An Imbalance between the Excretion of Thromboxane and Prostacyclin Metabolites in Pulmonary Hypertension
1992
Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin)
2001
Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial
2002
Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men
2001
Effects of Long-Term Bosentan in Children With Pulmonary Arterial Hypertension
2005
Endothelium-derived mediators and hypoxic pulmonary vasoconstriction
2002
Tissue engineering a blood vessel: Regulation of vascular biology by mechanical stresses
1994
Statin effects beyond lipid lowering—are they clinically relevant?
2003
Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes<SUBTITLE>The MIRACL Study: A Randomized Controlled Trial</SUBTITLE>
2001 Standout
Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study
2000
Increased vascular contractility in isolated vessels from cigarette smoking rats is mediated by basal endothelin release
2006
Endothelin antagonists
1999
Inhibition of myocardial endothelin pathway improves long-term survival in heart failure
1996 Nature
Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1α-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer
2007
Pulmonary endothelium in acute lung injury: from basic science to the critically ill
2004
Big Endothelin-1 and Endothelin-1 Plasma Levels Are Correlated With the Severity of Primary Pulmonary Hypertension
2001
Autophagy in Human Health and Disease
2013 Standout
Endothelin—Biology and disease
2010
Bosentan Therapy for Pulmonary Arterial Hypertension
2002 Standout
Effects of Early Treatment With Statins on Short-term Clinical Outcomes in Acute Coronary Syndromes
2006
Hypoxia induces a functionally significant and translationally efficient neuronal NO synthase mRNA variant
2005
The Central Role of Endothelial Dysfunction in Cardiorenal Syndrome
2016
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Polycystic Ovary Syndrome
2005 Standout
Autophagic Protein LC3B Confers Resistance against Hypoxia-induced Pulmonary Hypertension
2010
Ambrisentan Therapy for Pulmonary Arterial Hypertension
2005
Phosphorylation and Desensitization of Human Endothelin A and B Receptors
1997 StandoutNobel
Regulatory Functions of the Vascular Endothelium
1990 StandoutNobel
Endothelial function and coronary artery disease
2001
Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
1993 Standout
The role of the endothelium in modulating vascular control in sepsis and related conditions
1999
Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients
2003 Standout
Structural and Functional Alteration of Blood Vessels Caused by Cigarette Smoking: An Overview of Molecular Mechanisms
2007
The new clinical trials on pharmacological treatment in pulmonary arterial hypertension
2002
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
The Role of Endothelin-1 in the Pathogenesis of Idiopathic Pulmonary Fibrosis
2010
Endothelin receptor subtypes and their role in transmembrane signaling mechanisms
1995
Early Statin Treatment Following Acute Myocardial Infarction and 1-Year Survival
2001
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study
2001
Mechanisms of Bone Metastasis
2004 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
2003 Standout
Endothelins: Pathophysiology and treatment implications in chronic heart failure
2005
Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials
2012
Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia.
1993
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
2005 Standout
Endothelial function
2002
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
Endothelin-1 in Acute Lung Injury and the Adult Respiratory Distress Syndrome
1993
Atherosclerosis
2001 Standout
Carbon Monoxide and Nitric Oxide Suppress the Hypoxic Induction of Vascular Endothelial Growth Factor Gene via the 5′ Enhancer
1998 StandoutNobel
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Biomarkers in Heart Failure
2008 Standout
Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate
1995
Early Impairment of Endothelial Structure and Function in Young Normal-Weight Women with Polycystic Ovary Syndrome
2004
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Ambrisentan, a Non‐peptide Endothelin Receptor Antagonist
2006
Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs
2011
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
2002 Standout
Relation between endothelial dysfunction and the acute coronary syndrome: implications for therapy
2000
Sitaxsentan Therapy for Pulmonary Arterial Hypertension
2003
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice
1998 StandoutNobel
Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice
1999
Role of Endothelial Dysfunction in Atherosclerosis
2004 Standout
Biology of the endothelium.
1997
Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney.
1996 StandoutNobel
The Transcriptional Program in the Response of Human Fibroblasts to Serum
1999 StandoutScience
Effect of a selective aldosterone receptor antagonist in myocardial infarction
2001
Autosomal dominant polycystic kidney disease: Localization of the second gene to chromosome 4q13–q23
1993
Hypoxia-inducible Factor-1 Mediates Transcriptional Activation of the Heme Oxygenase-1 Gene in Response to Hypoxia
1997 StandoutNobel
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
2001 Standout
Pulmonary Arterial Hypertension
2006
Pulmonary Capillary Endothelium-Bound Angiotensin-Converting Enzyme Activity in Humans
1999
Functional Arteries Grown in Vitro
1999 StandoutScience
Endothelin and Collagen Vascular Disease: A Review with Special Reference to Raynaud's Phenomenon and Systemic Sclerosis.
1994
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
PKD2 , a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein
1996 StandoutScience
Increased Levels of Endothelin-1 in Plasma of Sickle Cell Anemia Patients
1998
Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart Failure
1997
Role of endothelium-derived relaxing factor in regulation of vascular tone and remodeling. Update on humoral regulation of vascular tone.
1991
Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.
1997
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
Effect of Cholesterol-Lowering Therapy on Coronary Endothelial Vasomotor Function in Patients With Coronary Artery Disease
2000
Targeting the Receptor-G q Interface to Inhibit in Vivo Pressure Overload Myocardial Hypertrophy
1998 StandoutScienceNobel
Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes
1998
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
2020 Standout
Neuropeptide variability in man
2000
Increased Levels of Endothelin-1 in Plasma of Sickle Cell Anemia Patients
1998
Statin Therapy in Acute Coronary Syndromes
2002
Prolonged desensitization of the human endothelin A receptor in Xenopus oocytes. Comparative studies with the human neurokinin A receptor.
1993
Secondary Pulmonary Hypertension in Chronic Heart Failure
2000
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction
1999 Standout
Works of Peter Černáček being referenced
Immunoreactive endothelin in human plasma: Marked elevations in patients in cardiogenic shock
1989
Newborn piglet lungs release endothelin-1: effect of α-thrombin and hypoxia
1993
INCREASED ENDOTHELIN EXPRESSION IN A RAT CARDIAC ALLOGRAFT MODEL OF CHRONIC VASCULAR REJECTION1
1996
Importance of Local Production of Endothelin-1 and of the ETBReceptor in the Regulation of Pulmonary Vascular Tone
2000
Increased plasma endothelin-1 in the early hours of acute myocardial infarction
1991
Increased Plasma Endothelin-1 in Pulmonary Hypertension: Marker or Mediator of Disease?
1991
Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension
1998
Enhancement of Aortic Contractility by Endothelin Following Prolonged Hypoxia in vivo
1998
The endothelin system and its role in acute myocardial infarction
2003
Specific endothelin binding sites in renal medullary collecting duct cells: lack of interaction with ANP binding and cGMP signalling
1992
The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats.
1997
Human Pulmonary Circulation Is an Important Site for Both Clearance and Production of Endothelin-1
1996
Radioreceptor assay of an endothelin A receptor antagonist in plasma and urine
1998
Endothelin-1 Regulates Tone of Isolated Small Arteries in the Rat
1998
Endothelin release is inhibited by coculture of endothelial cells with cells of vascular media
1990
Reduced Pulmonary Clearance of Endothelin-1 Contributes to the Increase of Circulating Levels in Heart Failure Secondary to Myocardial Infarction
1998
Endothelin A Receptor Blockade Causes Adverse Left Ventricular Remodeling but Improves Pulmonary Artery Pressure After Infarction in the Rat
1998
Cholesterol Reduction Rapidly Improves Endothelial Function After Acute Coronary Syndromes
1999
Lack of Role for Nitric Oxide (NO) in the Selective Destabilization of Endothelial NO Synthase mRNA by Tumor Necrosis Factor–α
1995
Elevated endothelin-1 in heart failure and loss of normal response to postural change.
1992
Renal dose response and pharmacokinetics of atrial natriuretic factor in dogs
1988